幹細胞バンキング市場：タイプ、サービス、供給源、用途別-2025-2030年の世界予測

幹細胞バンキング市場は、2023年に145億4,000万米ドルと評価され、2024年には169億8,000万米ドルに達すると予測され、CAGR 17.22％で成長し、2030年には442億4,000万米ドルになると予測されています。

幹細胞バンキング市場は、臍帯血、胚性幹細胞、成体幹細胞を含む、将来の医療利用の可能性を秘めた幹細胞の収集、加工、保存によって定義されます。幹細胞バンキングの必要性は、再生医療や幅広い遺伝性疾患、血液関連疾患、変性疾患の治療におけるその可能性に由来します。用途は個別化医療、研究イニシアティブ、治療開発にも及び、病院、研究所、バイオテクノロジー企業などのエンドユーザー層が多いです。

幹細胞研究と治療法の進歩、臍帯血バンクの利点に対する認知度の向上、政府機関や民間団体による投資の拡大などが、成長の主な要因です。医療インフラが発展し、先進医療へのアクセスを求める中産階級が増加している新興国市場にはチャンスが存在します。さらに、凍結保存と細胞処理における技術の進歩は、効率改善とコスト削減の道を示しています。こうした機会を活用するため、企業はヘルスケアプロバイダーや研究機関との提携、革新的な保存ソリューションの提供、一般向け啓発キャンペーンへの参加に注力すべきです。

しかし、市場の拡大には厳しい規制の枠組み、高い運営コスト、胚性幹細胞の使用に関する倫理的な懸念が課題となっています。このような制約から、企業は世界の規制を乗り切るための投資を行い、透明性の高い実践と教育を通じて倫理的配慮に取り組む必要があります。技術革新に向けた調査分野としては、細胞生存技術の強化、より良いマッチングと利用のためのAIの統合、利用者を増やすための革新的な支払いモデルなどが挙げられます。

幹細胞バンキング市場は、急速な技術進化と高度な専門性を特徴としています。コラボレーションを重視し、最先端技術を採用し、倫理的な透明性を維持することで、企業はこの将来性の高い分野の原動力を活用し、持続的な成長を達成することができます。

市場力学：急速に進化する幹細胞バンキング市場の主要市場インサイトを公開

幹細胞バンキング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 幹細胞の治療可能性に対する認識の高まり
  • 造血幹細胞移植の進歩
  • 幹細胞を用いた研究への投資促進
• 市場抑制要因
  • 幹細胞バンキングを購入できる価格の制限
  • 厳しい規制の枠組み
• 市場機会
  • 新興国からの需要の増加と可能性
  • 幹細胞の保存、保管、加工に関する技術開発
• 市場の課題
  • 胚性幹細胞に関する社会倫理的懸念

ポーターの5つの力：幹細胞バンキング市場をナビゲートする戦略的ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：幹細胞バンキング市場における外部からの影響の把握

外部マクロ環境要因は、幹細胞バンキング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析幹細胞バンキング市場における競合情勢の把握

幹細胞バンキング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス幹細胞バンキング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、幹細胞バンキング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨幹細胞バンキング市場における成功への道筋を描く

幹細胞バンキング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 幹細胞の治療の可能性に対する認識の高まり
    • 造血幹細胞移植の進歩
    • 投資に適した幹細胞調査
  • 抑制要因
    • 幹細胞バンキングの手頃な価格が限られている
    • 厳格な規制枠組み
  • 機会
    • 新興国からの需要と潜在力の増大
    • 幹細胞の保存・保管・処理に関する技術開発
  • 課題
    • 胚性幹細胞に関する社会倫理的懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 幹細胞バンキング市場：タイプ別

• 臍帯血
• 臍帯組織

第7章 幹細胞バンキング市場：サービス別

• 分析
• コレクション
• 処理
• ストレージ
• 交通機関

第8章 幹細胞バンキング市場：ソース別

• 脂肪組織由来幹細胞
• 骨髄由来幹細胞
• 歯髄由来幹細胞
• ヒト胚由来幹細胞
• 胎盤幹細胞

第9章 幹細胞バンキング市場：用途別

• 臨床調査
• パーソナライズされたバンキング

第10章 南北アメリカの幹細胞バンキング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の幹細胞バンキング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの幹細胞バンキング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Amag Pharmaceuticals, Inc.
• Americord Registry LLC
• BrainStorm Cell Therapeutics, Inc.
• Cellectis SA
• Cord Blood America, Inc.
• Cordlife Sciences India Pvt. Ltd.
• CordVida
• Cryo-Cell International, Inc.
• CryoHoldco de Latinoamerica, S.A.P.I. de C.V.
• Cryoviva Biotech Private Limited
• Global Cord Blood Corporation
• Human Longevity, Inc
• LifeCell International Private Limited
• Lifeforce Cryobank Sciences, Inc.
• PerkinElmer, Inc.

LIST OF FIGURES

• FIGURE 1. STEM CELL BANKING MARKET RESEARCH PROCESS
• FIGURE 2. STEM CELL BANKING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL STEM CELL BANKING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL STEM CELL BANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL STEM CELL BANKING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL STEM CELL BANKING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL STEM CELL BANKING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL STEM CELL BANKING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL STEM CELL BANKING MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL STEM CELL BANKING MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES STEM CELL BANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES STEM CELL BANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. STEM CELL BANKING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. STEM CELL BANKING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. STEM CELL BANKING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL STEM CELL BANKING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL STEM CELL BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. STEM CELL BANKING MARKET DYNAMICS
• TABLE 7. GLOBAL STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL STEM CELL BANKING MARKET SIZE, BY CORD TISSUE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL STEM CELL BANKING MARKET SIZE, BY ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL STEM CELL BANKING MARKET SIZE, BY COLLECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL STEM CELL BANKING MARKET SIZE, BY PROCESSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL STEM CELL BANKING MARKET SIZE, BY STORAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL STEM CELL BANKING MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE-DERIVED STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL STEM CELL BANKING MARKET SIZE, BY BONE MARROW-DERIVED STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL STEM CELL BANKING MARKET SIZE, BY DENTAL PULP-DERIVED STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL STEM CELL BANKING MARKET SIZE, BY HUMAN EMBRYO-DERIVED STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL STEM CELL BANKING MARKET SIZE, BY PLACENTAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL STEM CELL BANKING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL STEM CELL BANKING MARKET SIZE, BY PERSONALIZED BANKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CANADA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 40. CANADA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES STEM CELL BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. CHINA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 62. CHINA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 63. CHINA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDIA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 66. INDIA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 67. INDIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. ITALY STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 135. ITALY STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 136. ITALY STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. POLAND STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 151. POLAND STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 152. POLAND STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. QATAR STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 155. QATAR STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 156. QATAR STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. STEM CELL BANKING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. STEM CELL BANKING MARKET, FPNV POSITIONING MATRIX, 2023

The Stem Cell Banking Market was valued at USD 14.54 billion in 2023, expected to reach USD 16.98 billion in 2024, and is projected to grow at a CAGR of 17.22%, to USD 44.24 billion by 2030.

The stem cell banking market is defined by the collection, processing, and storage of stem cells for potential future medical use, often involving umbilical cord blood, embryonic stem cells, and adult stem cells. The necessity of stem cell banking stems from its potential in regenerative medicine and treatment of a wide array of genetic disorders, blood-related diseases, and degenerative conditions. Applications extend to personalized medicine, research initiatives, and therapeutic developments, with significant end-user demographics including hospitals, research laboratories, and biotechnology firms.

Key growth influences encompass advancements in stem cell research and therapies, increasing awareness of cord blood banking benefits, and expanding investments by governmental and private organizations. Opportunities exist in emerging markets where healthcare infrastructure is developing, and there's a growing middle class seeking access to advanced medical options. Furthermore, technological advancements in cryopreservation and cell processing present avenues for efficiency improvements and cost reductions. To leverage these opportunities, businesses should focus on partnerships with healthcare providers and research institutions, offering innovative storage solutions, and participating in public awareness campaigns.

However, market expansion is challenged by stringent regulatory frameworks, high operational costs, and ethical concerns regarding embryonic stem cell use. These limitations necessitate businesses to invest in navigating global regulations and addressing ethical considerations through transparent practices and education. Research areas poised for innovation include enhanced cell viability techniques, integration of AI for better matching and utilization, and innovative payment models to increase user base.

The stem cell banking market is characterized by rapid technological evolution and a high degree of specialization. By focusing on collaboration, adopting cutting-edge technologies, and maintaining ethical transparency, businesses can harness the drives of this high-potential sector to achieve sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Stem Cell Banking Market

The Stem Cell Banking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising awareness of the therapeutic potential of stem cells
  • Advance hematopoietic stem cell transplantation procedures
  • Investment friendly stem cell-based research
• Market Restraints
  • Limited affordability of stem cell banking
  • Stringent regulatory frameworks
• Market Opportunities
  • Increasing demand and potential from emerging countries
  • Technology development related to stem cell preservation, storage, and processing
• Market Challenges
  • Socio-ethical concerns related to embryonic stem cells

Porter's Five Forces: A Strategic Tool for Navigating the Stem Cell Banking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Stem Cell Banking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Stem Cell Banking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Stem Cell Banking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Stem Cell Banking Market

A detailed market share analysis in the Stem Cell Banking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Stem Cell Banking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Stem Cell Banking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Stem Cell Banking Market

A strategic analysis of the Stem Cell Banking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Stem Cell Banking Market, highlighting leading vendors and their innovative profiles. These include Amag Pharmaceuticals, Inc., Americord Registry LLC, BrainStorm Cell Therapeutics, Inc., Cellectis SA, Cord Blood America, Inc., Cordlife Sciences India Pvt. Ltd., CordVida, Cryo-Cell International, Inc., CryoHoldco de Latinoamerica, S.A.P.I. de C.V., Cryoviva Biotech Private Limited, Global Cord Blood Corporation, Human Longevity, Inc, LifeCell International Private Limited, Lifeforce Cryobank Sciences, Inc., and PerkinElmer, Inc..

Market Segmentation & Coverage

This research report categorizes the Stem Cell Banking Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Cord Blood and Cord Tissue.
• Based on Service, market is studied across Analysis, Collection, Processing, Storage, and Transportation.
• Based on Source, market is studied across Adipose Tissue-Derived Stem Cells, Bone Marrow-Derived Stem Cells, Dental Pulp-Derived Stem Cells, Human Embryo-Derived Stem Cells, and Placental Stem Cells.
• Based on Application, market is studied across Clinical Research and Personalized Banking.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising awareness of the therapeutic potential of stem cells
    • 5.1.1.2. Advance hematopoietic stem cell transplantation procedures
    • 5.1.1.3. Investment friendly stem cell-based research
  • 5.1.2. Restraints
    • 5.1.2.1. Limited affordability of stem cell banking
    • 5.1.2.2. Stringent regulatory frameworks
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing demand and potential from emerging countries
    • 5.1.3.2. Technology development related to stem cell preservation, storage, and processing
  • 5.1.4. Challenges
    • 5.1.4.1. Socio-ethical concerns related to embryonic stem cells
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Stem Cell Banking Market, by Type

• 6.1. Introduction
• 6.2. Cord Blood
• 6.3. Cord Tissue

7. Stem Cell Banking Market, by Service

• 7.1. Introduction
• 7.2. Analysis
• 7.3. Collection
• 7.4. Processing
• 7.5. Storage
• 7.6. Transportation

8. Stem Cell Banking Market, by Source

• 8.1. Introduction
• 8.2. Adipose Tissue-Derived Stem Cells
• 8.3. Bone Marrow-Derived Stem Cells
• 8.4. Dental Pulp-Derived Stem Cells
• 8.5. Human Embryo-Derived Stem Cells
• 8.6. Placental Stem Cells

9. Stem Cell Banking Market, by Application

• 9.1. Introduction
• 9.2. Clinical Research
• 9.3. Personalized Banking

10. Americas Stem Cell Banking Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Stem Cell Banking Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Stem Cell Banking Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amag Pharmaceuticals, Inc.
• 2. Americord Registry LLC
• 3. BrainStorm Cell Therapeutics, Inc.
• 4. Cellectis SA
• 5. Cord Blood America, Inc.
• 6. Cordlife Sciences India Pvt. Ltd.
• 7. CordVida
• 8. Cryo-Cell International, Inc.
• 9. CryoHoldco de Latinoamerica, S.A.P.I. de C.V.
• 10. Cryoviva Biotech Private Limited
• 11. Global Cord Blood Corporation
• 12. Human Longevity, Inc
• 13. LifeCell International Private Limited
• 14. Lifeforce Cryobank Sciences, Inc.
• 15. PerkinElmer, Inc.